Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung.

Hypersecretion of airway mucus is a characteristic feature of chronic airway diseases like cystic fibrosis (CF) and leads via impairment of the muco-ciliary clearance and bacterial superinfection to respiratory failure. The major components of the mucus matrix forming family of mucins in the airways are MUC5AC and MUC5B. To investigate the expression of these glycoproteins in CF, immunohistochemistry was carried out on trachea, bronchi and peripheral lung obtained from CF patients and compared to normal lung tissues. MUC5AC immunohistochemistry demonstrated signals in goblet cells of the epithelial lining. Also, goblet cells inside glandular secretory ducts revealed MUC5AC-positive staining. In comparison to those from normal subjects, CF sections were characterized by inflammatory changes and goblet cell hyperplasia, resulting in increased numbers of MUC5AC-positive cells. Immunohistochemical staining for MUC5B showed abundant staining of submucosal glands and epithelial goblet cells. Inside the glands, the immunoreactivity was restricted to glandular mucous cells. MUC5AC and MUC5B are expressed in the same histological pattern in CF compared to normal tissues with an increase of MUC5AC-positive cells due to goblet cell hyper- and metaplasia.

[1]  J. Davies,et al.  MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions , 1996, Glycoconjugate Journal.

[2]  R. Wu,et al.  Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. , 2001, American journal of respiratory and critical care medicine.

[3]  J. Davies,et al.  Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions. , 1999, The Biochemical journal.

[4]  E. Veerman,et al.  MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage. , 1998, The Biochemical journal.

[5]  Jian-Dong Li,et al.  Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Jian-Dong Li,et al.  Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria. , 1998, Biochimica et biophysica acta.

[7]  F. Verheugt.  Aspirin, the poor man's statin? , 1998, The Lancet.

[8]  M. Hollingsworth,et al.  MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways. , 1998, American journal of respiratory cell and molecular biology.

[9]  H. Wandall,et al.  Identification of a major human high molecular weight salivary mucin (MG1) as tracheobronchial mucin MUC5B. , 1997, Glycobiology.

[10]  Dechun Li,et al.  Localization and up‐regulation of Mucin (MUC2) gene expression in human nasal biopsies of patients with cystic fibrosis , 1997, The Journal of pathology.

[11]  R. Stern,et al.  The diagnosis of cystic fibrosis. , 1997, The New England journal of medicine.

[12]  J. D. Li,et al.  Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Davies,et al.  Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells. , 1996, The Biochemical journal.

[14]  B. Ramsey,et al.  Management of pulmonary disease in patients with cystic fibrosis. , 1996, The New England journal of medicine.

[15]  J. Sheehan,et al.  Mucins in airway secretions from healthy and chronic bronchitic subjects. , 1996, The Biochemical journal.

[16]  Y Zhang,et al.  Genotypic analysis of respiratory mucous sulfation defects in cystic fibrosis. , 1995, The Journal of clinical investigation.

[17]  S. Gendler,et al.  Epithelial mucin genes. , 1995, Annual review of physiology.

[18]  M. Hollingsworth,et al.  Developmental expression of mucin genes MUC1 and MUC2. , 1994, Journal of cell science.

[19]  M. Copin,et al.  Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[20]  N. Høiby,et al.  Pathogenesis of cystic fibrosis , 1993, The Lancet.

[21]  R Gupta,et al.  The structure of tracheobronchial mucins from cystic fibrosis and control patients. , 1992, The Journal of biological chemistry.

[22]  James M. Wilson,et al.  Submucosal glands are the predominant site of CFTR expression in the human bronchus , 1992, Nature Genetics.

[23]  H. Lindgren,et al.  Mucus glycoproteins from cystic fibrotic sputum. Macromolecular properties and structural 'architecture'. , 1991, The Biochemical journal.

[24]  Y. Kim,et al.  Human bronchus and intestine express the same mucin gene. , 1991, The Journal of clinical investigation.

[25]  D. Thornton,et al.  Mucus glycoproteins from 'normal' human tracheobronchial secretion. , 1990, The Biochemical journal.

[26]  K V Chace,et al.  Comparison of physicochemical properties of purified mucus glycoproteins isolated from respiratory secretions of cystic fibrosis and asthmatic patients. , 1985, Biochemistry.

[27]  T. Boat,et al.  Biochemistry of airway mucus secretions. , 1980, Federation proceedings.

[28]  D. M. Carlson,et al.  Human respiratory tract secretion. Mucous glycoproteins of nonpurulent tracheobronchial secretions, and sputum of patients with bronchitis and cystic fibrosis. , 1976, Archives of biochemistry and biophysics.

[29]  G. Lamblin,et al.  Heterogeneity of the carbohydrate chains of sulfated bronchial glycoproteins isolated from a patient suffering from cystic fibrosis. , 1975, The Journal of biological chemistry.